Corneal cross-linking for keratoconus

Riboflavin (vitamin B2) drops are applied to the cornea, then the cornea is exposed to controlled ultraviolet light. Together they help form extra bonds between collagen fibers, making the cornea stiffer so it resists further bulging.

Cross-linking addresses progression. It is not designed mainly to sharpen vision, and stabilization does not guarantee normal vision. Most people still rely on glasses or contact lenses afterward, sometimes with a new prescription or fit once the eye settles.

Because cross-linking aims to strengthen the cornea as it is, it works on the shape that exists at the time of treatment. Distortion and any scarring already present usually remain, so the vision plan, such as glasses or specialty lenses, continues afterward. This is part of why clinicians discuss treatment while an eye is changing, rather than waiting for vision to become much worse.

Treatment is not always the last step. If keratoconus continues to change, or vision cannot be corrected well enough, a cornea specialist may discuss other options for selected eyes, such as ring segments, or a transplant for selected advanced cases. Those decisions are individual, and many people never need them.

Your clinician looks at whether your scans show progression, or whether your situation suggests a high risk of it. Corneal thickness, the overall health of the eye, prior surgery and other conditions also matter, and so does which method would be used. Not everyone with keratoconus is a candidate, and not every cornea progresses.

Progression is not decided by one number. Clinicians compare several measurements from reliable scans over time, along with changes in vision and prescription. Age matters too: younger patients tend to have a higher risk of change, which is one reason treatment may be discussed earlier for them.

A product label age is not a minimum age for having keratoconus or for being evaluated. It describes the population the product was studied and approved for.

Sometimes the recommendation is to monitor rather than treat now, for example when scans do not yet show clear change. Monitoring is an active plan, not a refusal of care. Ask when the next comparison is due, what kind of change would lead to a treatment discussion, and who will review the scans if more than one office is involved.

Between visits, report new blur, frequent prescription changes or lens fit problems rather than waiting for the scheduled date. Keep the follow-up visit even if vision feels unchanged, because change in the cornea can come before you notice it. If you would like a second opinion before deciding either way, it is reasonable to ask for copies of your scans to take with you.

Exact steps, timing and recovery differ by method and by patient, so your team will describe its own plan.

In "epi-off" methods, the thin surface layer of the cornea (the epithelium) is removed first. In "epi-on" methods it is left in place. No method is presented here as better for everyone.

In the U.S., the PHOTREXA/KXL labeling covers an epithelium-off procedure for progressive keratoconus, and states that safety and effectiveness below age 14 have not been established. The EPIOXA labeling (revised October 2025) covers an epithelium-on procedure for keratoconus in people aged 13 and older, used specifically with the O2n System and Boost Goggles. That approval does not cover every epi-on protocol.

These label ages are not a minimum age for diagnosis. Younger children with keratoconus still need expert evaluation, and their options are a specialist discussion. Ask which method and product your clinician uses and its approval status for your age.

A label is not the same as availability. In March 2026 the maker of EPIOXA announced it was commercially available in the United States, and offices may change which product they use over time. Ask which method and which product your office would use for you, at which location, and whether it matches an FDA label for your age.

Practical planning reduces stress. Your team will give its own instructions; the points below are what to ask about, not fixed times.

Numbing eye drops are used during the procedure. Ask the team how comfort is managed and whether any anesthesia or sedation is considered; this is decided individually, particularly for a young child. With epithelium-off methods the surface layer is removed first, and a protective bandage contact lens is often placed afterward while it heals. Arrange for someone to drive you home, since your vision will be blurred and your eye may be sensitive to light.

Most offices give written instructions about contact lens wear before the procedure, eye drops afterward and who to call. Ask for them in advance so you can arrange time off school or work, a ride home and any help at home. For a young child, ask how comfort and, where relevant, anesthesia will be handled, because that is decided for each child by the treating team.

• Ask how long you will be at the office and whether one or both eyes are treated that day.
• Ask when you can expect to return to school, work and screens for the method used, and plan time off with some flexibility.
• Ask which drops you will use afterward, how often, and what to do if one runs out.
• Ask when you can drive again; the answer depends on your vision in each eye after treatment.

Recovery depends on the method. When the surface layer is removed, discomfort or pain and blurry vision are common while it heals, and a protective contact lens may be used. Possible risks include delayed or problematic healing of the surface, infection, corneal haze and changes in vision. Your team will explain which risks apply to their method.

Follow your treating team's instructions for drops, activities and follow-up. It helps to think of recovery as three separate milestones. A healed surface is not the same as final vision, and good vision soon after treatment is not proof of long-term stability:

• Surface healing: with epithelium-off methods the removed surface layer has to regrow. This is when discomfort, light sensitivity and blur are most noticeable, and a protective contact lens may be used.
• Functional vision and lens refit: after the surface heals, vision can keep changing while the eye settles, so your team times a new prescription or lens fitting rather than doing it straight away.
• Long-term stability: whether treatment has slowed or stopped keratoconus is judged by your clinician, who interprets repeat, comparable measurements and eye examinations over time. Stability is not guaranteed, and there is no fixed date when it is confirmed.

Some discomfort, light sensitivity and blur are expected, especially after epithelium-off treatment. Call the office promptly if pain gets worse instead of better, if vision drops suddenly, if redness or discharge increases, or if the bandage lens comes out. Infection, delayed healing and corneal haze are listed risks, so these calls matter.

Monitoring continues. Repeat scans show whether the cornea has stabilized, and some people need further treatment. A new lens fitting may be needed once the eye settles.

Some offices perform cross-linking themselves; others diagnose and monitor, then refer you elsewhere. Both are common. Directory listings show which one a source describes, and mark it unknown when the source is silent.

Coverage depends on your plan, the product and how the service is billed. Ask the office for a written estimate that names the procedure and product, and ask your insurer whether prior authorization is needed. Prior authorization is not a promise of payment. Our costs guide includes a ready-to-use call script.

If coverage is uncertain, ask the office whether a prior authorization request will be submitted before the treatment date, and who will tell you the result. Prior authorization is not a payment guarantee, so also ask what you might owe if a claim is later denied, and whether follow-up visits are billed separately.